Correlation Between INFORMATION SVC and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INFORMATION SVC and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INFORMATION SVC and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INFORMATION SVC GRP and Pfizer Inc, you can compare the effects of market volatilities on INFORMATION SVC and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INFORMATION SVC with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of INFORMATION SVC and Pfizer.

Diversification Opportunities for INFORMATION SVC and Pfizer

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between INFORMATION and Pfizer is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding INFORMATION SVC GRP and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and INFORMATION SVC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INFORMATION SVC GRP are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of INFORMATION SVC i.e., INFORMATION SVC and Pfizer go up and down completely randomly.

Pair Corralation between INFORMATION SVC and Pfizer

Assuming the 90 days horizon INFORMATION SVC GRP is expected to generate 1.3 times more return on investment than Pfizer. However, INFORMATION SVC is 1.3 times more volatile than Pfizer Inc. It trades about 0.15 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.04 per unit of risk. If you would invest  288.00  in INFORMATION SVC GRP on September 19, 2024 and sell it today you would earn a total of  58.00  from holding INFORMATION SVC GRP or generate 20.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

INFORMATION SVC GRP  vs.  Pfizer Inc

 Performance 
       Timeline  
INFORMATION SVC GRP 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in INFORMATION SVC GRP are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, INFORMATION SVC reported solid returns over the last few months and may actually be approaching a breakup point.
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

INFORMATION SVC and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INFORMATION SVC and Pfizer

The main advantage of trading using opposite INFORMATION SVC and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INFORMATION SVC position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind INFORMATION SVC GRP and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities